Ardelyx (ARDX) Gross Profit (QoQ) (2018 - 2026)
Ardelyx (ARDX) Gross Profit (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.28 Bn | 463.49 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.49 Bn | 115.24 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.26 Bn | 61.51 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.67 Bn | 50.48 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.60% |
| Dec 31, 2025 | 19,750.52% |
| Sep 30, 2025 | -100.68% |
| Jun 30, 2025 | 37.93% |
| Mar 31, 2025 | -36.84% |
| Dec 31, 2024 | 18.61% |
| Sep 30, 2024 | 29.36% |
| Jun 30, 2024 | 64.00% |
| Mar 31, 2024 | 32.81% |
| Dec 31, 2023 | -39.86% |
| Sep 30, 2023 | 158.43% |
| Jun 30, 2023 | 91.66% |
| Mar 31, 2023 | -76.03% |
| Dec 31, 2022 | 864.17% |
| Sep 30, 2022 | 78.14% |
| Jun 30, 2022 | 523.50% |
| Mar 31, 2022 | -62.78% |
| Dec 31, 2021 | -12.28% |
| Sep 30, 2021 | -10.66% |
| Jun 30, 2021 | -76.48% |